Drug Trial Radar · NCT00314184
Quetiapine Fumarate Bipolar Maintenance Monotherapy
Last checked: Nov 19, 2026Latest source record: Dec 22, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,255
Actual
Start
Mar 2005
Primary completion
Not stated
Study completion Jul 2007
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Apr 13, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, parallel-group, double-blind, placebo-controlled study to evaluate the efficacy and safety of quetiapine and lithium (comparator in the study) for up to 104 weeks of maintenance treatment in adult patients with Bipolar I Disorder. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
Conditions
- Bipolar Disorder
Interventions
quetiapine fumarateDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time from randomization to recurrence of a mood event
Locations
95 sites in 15 countries. Site status is shown where the registry gives one.
Research Site
Cerritos, California
Research Site
San Diego, California
Research Site
Santa Ana, California
Research Site
Washington D.C., District of Columbia
Research Site
Gainesville, Florida
Research Site
Jacksonville, Florida
Research Site
North Miami, Florida
Research Site
Orlando, Florida
Research Site
Atlanta, Georgia
Research Site
Eagle, Idaho
Research Site
Hoffman Estates, Illinois
Research Site
Terre Haute, Indiana
Research Site
Shreveport, Louisiana
Research Site
Flowood, Mississippi
Research Site
Saint Charles, Missouri
Research Site
Las Vegas, Nevada
Research Site
Clementon, New Jersey
Research Site
Rochester, New York
Research Site
Raleigh, North Carolina
Research Site
Fargo, North Dakota
Research Site
Portland, Oregon
Research Site
Salem, Oregon
Research Site
Philadelphia, Pennsylvania
Research Site
Memphis, Tennessee
Research Site
Austin, Texas
Research Site
Lake Jackson, Texas
Research Site
Richmond, Virginia
Research Site
Bellevue, Washington
Research Site
Kirkland, Washington
Research Site
Seattle, Washington
Research Site
Capital Federal, Argentina
Research Site
Córdoba, Argentina
Research Site
La Plata, Argentina
Research Site
Lanus, Argentina
Research Site
Mendoza, Argentina
Research Site
Rosario, Argentina
Research Site
Burgas, Bulgaria
Research Site
Plovdiv, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Antioquia, Colombia
Showing 40 of 95 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.